Page 1,719«..1020..1,7181,7191,7201,721..1,7301,740..»

Jean-Michel Basquiat: The Anatomy of Suffering – Center for Research on Globalization

Posted: Published on June 10th, 2017

The Chiostro Del Bramante, a cloister-turned-gallery in the heart of Rome, is currently presenting Jean-Michel Basquiat: New York City a generous selection of work spanning the short, but immensely prolific, career of this extraordinary artist. The extensive exhibition includes nearly one hundred significant works on loan from the Mugrabi Collection, which includes acrylics and oils, as well as drawings, silkscreen prints, and ceramics completed between the years of 1981 and 1987. Born in Brooklyn, New York to a Haitian father and Puerto Rican mother, Basquiats stunning and breathtakingly rapid ascent to fame and stardom was paralleled by few, if any, other artists in the twentieth century. At Sothebys recently, Basquiats painting of a skull, Untitled (1982) sold for $110.5 million a record price for an American painter, placing him in the art history pantheon alongside Pablo Picasso and Francis Bacon. We can be pleased that Yusaku Maezawa, the Japanese billionaire who bought the painting, intends to share his taste for art with the public. However, if we are to truly approach these works at all, it is necessary to get beyond the din of the market the screeching vultures as the late John Berger puts it and give our attention … Continue reading →

Posted in Anatomy | Comments Off on Jean-Michel Basquiat: The Anatomy of Suffering – Center for Research on Globalization

Anatomy of a clusterfuck: How 'strong and stable' Theresa May messed up so entirely – The Spinoff

Posted: Published on June 10th, 2017

What the hell just happened? The Guardians Richard Adams attempts to make sense of the shock UK election outcome. The UK election result is the biggest upset of conventional wisdom since, well, last November. After Trump, the Brexit referendum, Leicester City winning the premier league and the 2015 UK general election result youd think wed be getting used to this. But no. The Conservative partys decision to call a snap election has backfired: rather than winning the comfortable-to-huge majority predicted, the Tories have instead gone backwards. The party has held enough seats to govern in coalition with Northern Irelands Democratic Unionist party but it was a miserable effort in almost every other respect. Nervous and ill-advised, Theresa May achieved the unthinkable: winning more than 42% of the popular vote but losing a swathe of seats in England. (In 2005 Tony Blair won 35% of the vote but a solid majority of MPs.) Labour under Jeremy Corbyn got around 40% and gained more than 30 seats. The Tories piled up wasted votes in safe seats and failed to go beyond their comfort zone to win votes in London and the east of England. And that in a nutshell is why May … Continue reading →

Posted in Anatomy | Comments Off on Anatomy of a clusterfuck: How 'strong and stable' Theresa May messed up so entirely – The Spinoff

Forbes Health Stories: New Tech Is Bringing Cardiology Into The Home – Forbes

Posted: Published on June 8th, 2017

Forbes Forbes Health Stories: New Tech Is Bringing Cardiology Into The Home Forbes Good morning, Forbes Health readers! Here are the great stories we published yesterday: Forbes Under 30 Alumni Score FDA Clearance For New Heart Monitor. The team is the second-youngest to gain a 510(k) clearance. The youngest? Themselves, with ... Read this article: Forbes Health Stories: New Tech Is Bringing Cardiology Into The Home - Forbes … Continue reading →

Posted in Cardiology | Comments Off on Forbes Health Stories: New Tech Is Bringing Cardiology Into The Home – Forbes

The Handoff: Your Week in Cardiology News – 6/9/17 – The Cardiology Advisor (registration)

Posted: Published on June 8th, 2017

The Handoff: Your Week in Cardiology News - 6/9/17 The Cardiology Advisor (registration) The Handoff is a weekly roundup of cardiology news covering various developments in subspecialties, as well as pharmaceutical industry, association, and society news. The FDA has approved an expanded indication for the Sapien 3 transcatheter heart ... and more » See original here: The Handoff: Your Week in Cardiology News - 6/9/17 - The Cardiology Advisor (registration) … Continue reading →

Posted in Cardiology | Comments Off on The Handoff: Your Week in Cardiology News – 6/9/17 – The Cardiology Advisor (registration)

Boehringer to host cardiology webinars – vet times

Posted: Published on June 8th, 2017

A two-part webinar series on mitral valve disease (MVD) is being hosted on the Boehringer Academy website. The online webinars which each count towards approximately 20 to 30 minutes of CPD cover: MVD: understand the heart of the problem is available on demand and presented by Kieran Borgeat US, European and RCVS specialist in veterinary cardiology at Langford Vets, University of Bristol. The webinar enables veterinary professionals to learn more about MVD, how it can be diagnosed and why the early detection of asymptomatic disease is crucial for optimising the outcome of MVD patients. Meaningful murmurs will take place at 8pm on 27 June and will be presented by Nuala Summerfield US, European and RCVS specialist in veterinary cardiology at New Priory Vets Brighton. The webinar will help veterinary professionals to accurately detect and interpret heart murmurs in dogs. Dr Summerfield will also explain how to localise the heart valves, grade and describe murmurs, and diagnose asymptomatic MVD. Meaningful murmurs will also be available to view on demand. Read more: Boehringer to host cardiology webinars - vet times … Continue reading →

Posted in Cardiology | Comments Off on Boehringer to host cardiology webinars – vet times

Puma Biotechnology’s Neratinib Set To Target Extended Adjuvant Opportunity – Seeking Alpha

Posted: Published on June 8th, 2017

Puma Biotechnology (NYSE:PBYI) is inching closer to its transformation from a research and development (or R&D) biopharmaceutical company to a full-fledged commercial organization. This company which has in-licensed development and commercialization rights for oral and intravenous formulations of irreversible tyrosine kinase inhibitor or TKI, neratinib, and also another irreversible TKI, PB357, achieved the first major milestone for 2017 on May 24, 2017. On this day, FDA's Oncologic Drugs Advisory Committee or ODAC recommended approval for Nerlynx (neratinib) as extended adjuvant therapy for patients suffering with early stage, human epidermal growth factor receptor type 2 - positive or HER2-positive breast cancer after being previously treated with surgery and adjuvant treatment with Roche Holdings' (OTCQX:RHHBY) Herceptin (trastuzumab). Besides this indication, Puma Biotechnology expects neratinib to demonstrate efficacy in other cancers such a non small cell lung cancer and tumors related to expression or over-mutation in HER2 such as HER2-positive cancer, HER-2 cancer that has metastasized to brain, HER2-positive neoadjuvant breast cancer. Hence, there is high probability that Neratinib can prove to be a blockbuster drug for Puma Biotechnology. I believe this is a solid reason for considering the company as a favorable investment opportunity in 2017. In this article, I will explain … Continue reading →

Posted in Biotechnology | Comments Off on Puma Biotechnology’s Neratinib Set To Target Extended Adjuvant Opportunity – Seeking Alpha

Global $92.9 Billion Biotechnology/Pharmaceutical Services … – PR Newswire (press release)

Posted: Published on June 8th, 2017

The global biotechnology services outsourcing market is expected to reach USD 92.9 billion by 2025 Pharmaceutical industry has been adaptive of the function of outsourcing certain clinical and corporate functions as early as 2002. Among the services outsourced, clinical trial management and contract manufacturing were the forerunners. For instance, Johnson & Johnson was the first pharmaceutical company to outsource its applications development and maintenance (ADM). In 2015, over USD 50.0 billion was spent on pharmaceutical R&D activities majorly on oncology, diabetes, and autoimmune therapy classes, which is expected to propel the biotechnology services outsourcing market growth over the forecast period. Shrinking profit margins coupled with rising competition in the market space, and augmenting regulatory burden are other vital impact rendering factors. The pharmaceutical services outsourcing market is expected to register growth at a CAGR of 8.7% during the forecast period. On the other hand, pending immigration legislations in the U.S. may hinder business economics and outsourcing risks. Pharmaceutical and biotechnology industries in Europe are significantly investing in R&D in the recent year owing to rising demand for advanced medicines. This may be attributed to increasing aging population, incidence of chronic diseases, and communicable diseases. Further key findings from the study … Continue reading →

Posted in Biotechnology | Comments Off on Global $92.9 Billion Biotechnology/Pharmaceutical Services … – PR Newswire (press release)

iShares NASDAQ Biotechnology Index (IBB) Receiving Somewhat … – The Cerbat Gem

Posted: Published on June 8th, 2017

iShares NASDAQ Biotechnology Index (IBB) Receiving Somewhat ... The Cerbat Gem News headlines about iShares NASDAQ Biotechnology Index (NASDAQ:IBB) have trended somewhat positive recently, according to AlphaOne Sentiment. Vetr Inc. Lowers iShares NASDAQ Biotechnology Index (IBB) to HoldSports Perspectives Private Management Group Inc. Raises Stake in iShares NASDAQ Biotechnology Index (IBB)Stock Observer Bellevue Group AG Has $3.52 Million Stake in iShares NASDAQ Biotechnology Index (IBB)Transcript Daily Markets Daily -BBNS -BangaloreWeekly all 14 news articles » Originally posted here: iShares NASDAQ Biotechnology Index (IBB) Receiving Somewhat ... - The Cerbat Gem … Continue reading →

Posted in Biotechnology | Comments Off on iShares NASDAQ Biotechnology Index (IBB) Receiving Somewhat … – The Cerbat Gem

Biology professor: Trump’s presidency will permanently alter human genetics – TheBlaze.com

Posted: Published on June 8th, 2017

A biology professor at the University of Washington in Seattle believes the stress caused by President Donald Trumps time in office will lead to a permanent change in human genetics. Peter Ward, a professor who works in the earth and space sciences department of UWs College of the Environment, offered his bizarre prediction to Gizmodo earlier this weekwhen the publication asked a handful of evolutionary biologists, Can superhuman mutants be living among us? Ward argued that significant traumas like abuse or military combat cancause permanent change to the human genome. He went on to suggest Trumps presidency is akin to those traumas and will have an evolutionary consequence on humanity. Were finding more and more that, for instance, people who have gone through combat, or women who have been abused when you have these horrendous episodes in life, it causes permanent change, which is then passed on to your kids, he said. These are actual genetic shifts that are taking place within people. Those shifts, Ward contended, can cause huge evolutionary change. He added: On a larger scale, the amount of stress that Americans are going through now, because of Trump there is going to be an evolutionary consequence. Earlier … Continue reading →

Posted in Biology | Comments Off on Biology professor: Trump’s presidency will permanently alter human genetics – TheBlaze.com

Other Views: Fix Biology Problem; Don’t Throw All Graduation Tests Away – Centralia Chronicle

Posted: Published on June 8th, 2017

Hundreds of Washington state high school seniors are still waiting to hear if they will be getting a diploma this month. Passing the state high school biology test, which current law requires them to pass before graduating, should not hold them up. The biology testing requirement should end as many lawmakers, school administrators, Washington State Board of Education members and the superintendent of public instruction all agree. However, the other two graduation exams in math and English are worthy and should remain. The biology test is no longer a relevant part of Washingtons graduation requirements as the state has adopted new science standards and is working on a new, more general science exam. With commencement ceremonies looming, state officials and lawmakers should hurry up and work out a deal to fix that problem and allow students otherwise eligible to graduate. The problem affects few students one or two at every Seattle high school, according to the school district. This week, a spokesman for the state superintendents office said the number is about 1,000 statewide and diminishing as students meet the requirement in other ways. Students should not fail to graduate because of an outdated requirement. The state Senate already has … Continue reading →

Posted in Biology | Comments Off on Other Views: Fix Biology Problem; Don’t Throw All Graduation Tests Away – Centralia Chronicle

Page 1,719«..1020..1,7181,7191,7201,721..1,7301,740..»